{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:49:55Z","timestamp":1786636195150,"version":"build-2736575974"},"reference-count":160,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/0301-4738.73700","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T03:40:55Z","timestamp":1291779655000},"page":"102","source":"Crossref","is-referenced-by-count":43,"title":["Neuroprotection in glaucoma"],"prefix":"10.4103","volume":"59","author":[{"given":"SushilK","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viney","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JonathanG","family":"Crowston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.73700-1","first-page":"299","volume-title":"Study design and methods and baseline characteristics of study patients","author":"The","year":"1994","journal-title":"Control Clin Trials"},{"key":"key-10.4103\/0301-4738.73700-2","first-page":"1639","volume-title":"The AGIS Investigators","author":"The","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-3","first-page":"487","volume-title":"Collaborative Normal-Tension Glaucoma Study Group","author":"Comparison","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-4","first-page":"776","volume-title":"Collaborative normal-tension glaucoma study","author":"Sommer","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-5","first-page":"1943","volume-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.73700-6","first-page":"1268","volume-title":"Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-7","first-page":"1540","volume-title":"Is neuroprotection a viable therapy for glaucoma?","author":"Weinreb","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-8","unstructured":"Weinreb RN. Glaucoma neuroprotection. Philadelphia, Pa.: Lippincott Williams and Wilkins; 2006."},{"key":"key-10.4103\/0301-4738.73700-9","first-page":"90","volume-title":"Neuroprotection in glaucoma","author":"Kaushik","year":"2003","journal-title":"J Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3859","issn-type":"print"},{"key":"key-10.4103\/0301-4738.73700-10","first-page":"S243","volume-title":"Relevance of the site of injury of glaucoma to neuroprotective strategies","author":"Levin","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-11","first-page":"409","volume-title":"Should we treat the brain in glaucoma?","author":"Gupta","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-12","first-page":"325","volume-title":"Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity","author":"Arundine","year":"2003","journal-title":"Cell Calcium"},{"key":"key-10.4103\/0301-4738.73700-13","first-page":"3483","volume-title":"Molecular basis of glutamate toxicity in retinal ganglion cells","author":"Sucher","year":"1997","journal-title":"Vision Res"},{"key":"key-10.4103\/0301-4738.73700-14","first-page":"1618","volume-title":"Chronic low-dose glutamate is toxic to retinal ganglion cells.Toxicity blocked by memantine","author":"Vorwerk","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-15","first-page":"28","volume-title":"Glaucoma, apoptosis, and neuroprotection","author":"McKinnon","year":"1997","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-16","first-page":"3460","volume-title":"Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats","author":"Quigley","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-17","first-page":"764","volume-title":"Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma","author":"Pease","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-18","first-page":"397","volume-title":"Social controls on cell survival and cell death","author":"Raff","year":"1992","journal-title":"Nature"},{"key":"key-10.4103\/0301-4738.73700-19","first-page":"695","volume-title":"Programmed cell death and the control of cell survival: Lessons from the nervous system","author":"Raff","year":"1993","journal-title":"Science"},{"key":"key-10.4103\/0301-4738.73700-20","first-page":"609","volume-title":"Trk receptors: Roles in neuronal signal transduction","author":"Huang","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"key-10.4103\/0301-4738.73700-21","first-page":"466","volume-title":"Programmed cell death of neonatal rat retinal ganglion cells due to turn-off expression of a novel 30-kD trophic factor and\/or the lack of this factor supplied from the superior colliculus","author":"Chau","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0301-4738.73700-22","first-page":"249","volume-title":"Embryonic chick retinal ganglion cells identified \"in vitro\".Their survival is dependent on a factor from the optic tectum","author":"Nurcombe","year":"1981","journal-title":"Exp Brain Res"},{"key":"key-10.4103\/0301-4738.73700-23","first-page":"969","volume-title":"Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat","author":"Rabacchi","year":"1994","journal-title":"Neuroscience"},{"key":"key-10.4103\/0301-4738.73700-24","first-page":"82","volume-title":"Neurotrophic factors and neuronal death","author":"Thoenen","year":"1987","journal-title":"Ciba Found Symp"},{"key":"key-10.4103\/0301-4738.73700-25","first-page":"268","volume-title":"Retrograde neurotrophin signaling: Trk-ing along the axon","author":"Ginty","year":"2002","journal-title":"Curr Opin Neurobiol"},{"key":"key-10.4103\/0301-4738.73700-26","first-page":"39","volume-title":"Neuronal death in glaucoma","author":"Quigley","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/0301-4738.73700-27","first-page":"240","volume-title":"Role of target tissue in regulating the development of retinal ganglion cells in the albino rat: Effects of kainate lesions in the superior colliculus","author":"Carpenter","year":"1986","journal-title":"J Comp Neurol"},{"key":"key-10.4103\/0301-4738.73700-28","first-page":"163","volume-title":"Retinal ganglion cell degeneration following loss of postsynaptic target neurons in the dorsal lateral geniculate nucleus of the adult cat","author":"Pearson","year":"1992","journal-title":"Exp Neurol"},{"key":"key-10.4103\/0301-4738.73700-29","first-page":"113","volume-title":"Atrophy and degeneration of ganglion cells in central retina following loss of postsynaptic target neurons in the dorsal lateral geniculate nucleus of the adult cat","author":"Pearson","year":"1993","journal-title":"Exp Neurol"},{"key":"key-10.4103\/0301-4738.73700-30","first-page":"165","volume-title":"Calcium, free radicals and excitotoxins in neuronal apoptosis","author":"Lipton","year":"1998","journal-title":"Cell Calcium"},{"key":"key-10.4103\/0301-4738.73700-31","first-page":"4898","volume-title":"Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy","author":"Leung","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-32","first-page":"1322","volume-title":"The Bcl-2 protein family: Arbiters of cell survival","author":"Adams","year":"1998","journal-title":"Science"},{"key":"key-10.4103\/0301-4738.73700-33","first-page":"245","volume-title":"Bcl-2 gene family in the nervous system","author":"Merry","year":"1997","journal-title":"Annu Rev Neurosci"},{"key":"key-10.4103\/0301-4738.73700-34","first-page":"S277","volume-title":"Maintaining mitochondrial membrane impermeability.an opportunity for new therapy in glaucoma?","author":"Tatton","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-35","first-page":"373","volume-title":"Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer","author":"Malik","year":"2005","journal-title":"Mol Ther"},{"key":"key-10.4103\/0301-4738.73700-36","first-page":"17","volume-title":"Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage","author":"Libby","year":"2005","journal-title":"PLoS Genet"},{"key":"key-10.4103\/0301-4738.73700-37","first-page":"389","volume-title":"Activation of caspase 9 in a rat model of experimental glaucoma","author":"Hanninen","year":"2002","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.73700-38","first-page":"1077","volume-title":"Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension","author":"McKinnon","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-39","first-page":"780","volume-title":"Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model","author":"McKinnon","year":"2002","journal-title":"Mol Ther"},{"key":"key-10.4103\/0301-4738.73700-40","unstructured":"Levin LA WR, Di Polo A. A Pocket Guide of Neuroprotection in Glaucoma. New York: Ethis Communications; 2007."},{"key":"key-10.4103\/0301-4738.73700-41","first-page":"146","volume-title":"Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx","author":"Das","year":"2006","journal-title":"Brain Res"},{"key":"key-10.4103\/0301-4738.73700-42","first-page":"346","volume-title":"Significant variation of the elevated nitric oxide levels in aqueous humor from patients with different types of glaucoma","author":"Tsai","year":"2002","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.73700-43","first-page":"497","volume-title":"Nitric oxide synthase in the human glaucomatous optic nerve head","author":"Neufeld","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-44","first-page":"950","volume-title":"The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding","author":"Motallebipour","year":"2005","journal-title":"Mol Vis"},{"key":"key-10.4103\/0301-4738.73700-45","first-page":"523","volume-title":"Activated microglia in the human glaucomatous optic nerve head","author":"Yuan","year":"2001","journal-title":"J Neurosci Res"},{"key":"key-10.4103\/0301-4738.73700-46","first-page":"178","volume-title":"Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head","author":"Liu","year":"2000","journal-title":"Glia"},{"key":"key-10.4103\/0301-4738.73700-47","first-page":"147","volume-title":"Nitrotyrosine formation and apoptosis in rat models of ocular injury","author":"Aslan","year":"2006","journal-title":"Free Radic Res"},{"key":"key-10.4103\/0301-4738.73700-48","first-page":"557","volume-title":"Direct imaging of NMDA-stimulated nitric oxide production in the retina","author":"Blute","year":"2000","journal-title":"Vis Neurosci"},{"key":"key-10.4103\/0301-4738.73700-49","first-page":"265","volume-title":"Nitric oxide synthase expression in the transient ischemic rat retina: Neuroprotection of betaxolol","author":"Cheon","year":"2002","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0301-4738.73700-50","first-page":"329","volume-title":"Change in endothelial nitric oxide synthase in the rat retina following transient ischemia","author":"Cheon","year":"2003","journal-title":"Neuroreport"},{"key":"key-10.4103\/0301-4738.73700-51","first-page":"707","volume-title":"The mitochondrial generation of hydrogen peroxide.General properties and effect of hyperbaric oxygen","author":"Boveris","year":"1973","journal-title":"Biochem J"},{"key":"key-10.4103\/0301-4738.73700-52","first-page":"580","volume-title":"Role of oxidative stress enzymes in open-angle glaucoma","author":"Yildirim","year":"2005","journal-title":"Eye"},{"key":"key-10.4103\/0301-4738.73700-53","first-page":"117","volume-title":"Cell signaling and neuronal death","author":"Hara","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key-10.4103\/0301-4738.73700-54","first-page":"339","volume-title":"Ca2+-induced apoptosis through calcineurin dephosphorylation of Bad","author":"Wang","year":"1999","journal-title":"Science"},{"key":"key-10.4103\/0301-4738.73700-55","first-page":"12242","volume-title":"Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma","author":"Huang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.73700-56","first-page":"175","volume-title":"Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix","author":"Guo","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-57","first-page":"2374","volume-title":"Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration","author":"Zhang","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-58","first-page":"473","volume-title":"Heat shock proteins, immunity and glaucoma","author":"Tezel","year":"2004","journal-title":"Brain Res Bull"},{"key":"key-10.4103\/0301-4738.73700-59","first-page":"331","volume-title":"Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity","author":"Moalem","year":"2000","journal-title":"J Autoimmun"},{"key":"key-10.4103\/0301-4738.73700-60","first-page":"49","volume-title":"Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy","author":"Moalem","year":"1999","journal-title":"Nat Med"},{"key":"key-10.4103\/0301-4738.73700-61","first-page":"3398","volume-title":"Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma","author":"Schori","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.73700-62","first-page":"7446","volume-title":"T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies","author":"Kipnis","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.73700-63","first-page":"634","volume-title":"Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients","author":"Gass","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-64","first-page":"83","volume-title":"Plasma and aqueous humor endothelin levels in primary open-angle glaucoma","author":"Tezel","year":"1997","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-65","unstructured":"Wirostko B, Ehrlich R, Harris A. The vascular theory in glaucoma. Glaucoma Today 2009; p. 25-7."},{"key":"key-10.4103\/0301-4738.73700-66","first-page":"409","volume-title":"TNF-alpha signaling in glaucomatous neurodegeneration","author":"Tezel","year":"2008","journal-title":"Prog Brain Res"},{"key":"key-10.4103\/0301-4738.73700-67","first-page":"447","volume-title":"Neuroprotection in ophthalmology: A review","author":"Barkana","year":"2004","journal-title":"Brain Res Bull"},{"key":"key-10.4103\/0301-4738.73700-68","first-page":"1627","volume-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.73700-69","first-page":"134","volume-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","author":"Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-70","first-page":"154","volume-title":"MK801-a neuroprotectant in rat hypertensive eyes","author":"Chaudhary","year":"1998","journal-title":"Brain Res"},{"key":"key-10.4103\/0301-4738.73700-71","first-page":"1347","volume-title":"Modulation of pro-survival and death-associated pathways under retinal ischemia\/reperfusion: Effects of NMDA receptor blockade","author":"Russo","year":"2008","journal-title":"J Neurochem"},{"key":"key-10.4103\/0301-4738.73700-72","first-page":"19","volume-title":"Neuroprotective effect of memantine demonstrated in vivo and in vitro","author":"Seif","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0301-4738.73700-73","first-page":"527","volume-title":"Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide","author":"Lipton","year":"1993","journal-title":"Trends Neurosci"},{"key":"key-10.4103\/0301-4738.73700-74","first-page":"1","volume-title":"Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia","author":"Kim","year":"2002","journal-title":"Korean J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-75","first-page":"450","volume-title":"Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned","author":"Osborne","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-76","first-page":"725","volume-title":"Pharmacological neuroprotection for glaucoma","author":"Chidlow","year":"2007","journal-title":"Drugs"},{"key":"key-10.4103\/0301-4738.73700-77","first-page":"489","volume-title":"Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells.A quantitative in vivo study","author":"Peinado-Ramon","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-78","first-page":"1632","volume-title":"Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells","author":"Mansour-Robaey","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.73700-79","first-page":"265","volume-title":"CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: The possible involvement of STAT3 pathway","author":"Ji","year":"2004","journal-title":"Eur J Neurosci"},{"key":"key-10.4103\/0301-4738.73700-80","first-page":"375","volume-title":"Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma","author":"Fu","year":"2009","journal-title":"Neuroscience"},{"key":"key-10.4103\/0301-4738.73700-81","first-page":"S151","volume-title":"Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death","author":"Nickells","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-82","first-page":"31240","volume-title":"Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma","author":"Zhou","year":"2005","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0301-4738.73700-83","first-page":"C817","volume-title":"Calcium, ATP, and ROS: A mitochondrial love-hate triangle","author":"Brookes","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"key-10.4103\/0301-4738.73700-84","first-page":"980","volume-title":"Ganglion cell death in glaucoma: What do we really know?","author":"Osborne","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-85","first-page":"339","volume-title":"Pathogenesis of ganglion \"cell death\" in glaucoma and neuroprotection: Focus on ganglion cell axonal mitochondria","author":"Osborne","year":"2008","journal-title":"Prog Brain Res"},{"key":"key-10.4103\/0301-4738.73700-86","first-page":"S25","volume-title":"Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer\u2032s disease: Anti-apoptosis by alpha-2-adrenergic receptor activation","author":"Tatton","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-87","first-page":"36","volume-title":"Caspase inhibitors block the retinal ganglion cell death following optic nerve transection","author":"Chaudhary","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"key-10.4103\/0301-4738.73700-88","first-page":"4656","volume-title":"Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo","author":"Kermer","year":"1998","journal-title":"J Neurosci"},{"key":"key-10.4103\/0301-4738.73700-89","first-page":"361","volume-title":"Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo","author":"Kermer","year":"1999","journal-title":"FEBS Lett"},{"key":"key-10.4103\/0301-4738.73700-90","first-page":"215","volume-title":"Death and neuroprotection of retinal ganglion cells after different types of injury","author":"Vidal-Sanz","year":"2000","journal-title":"Neurotox Res"},{"key":"key-10.4103\/0301-4738.73700-91","first-page":"4023","volume-title":"Apoptotic death of beta cells after optic nerve transection in adult cats","author":"Kurimoto","year":"2003","journal-title":"J Neurosci"},{"key":"key-10.4103\/0301-4738.73700-92","first-page":"295","volume-title":"Neuroprotection in glaucoma using calpain-1 inhibitors: Regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics","author":"Govindarajan","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"key-10.4103\/0301-4738.73700-93","first-page":"221","volume-title":"A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma","author":"Neufeld","year":"2002","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-94","first-page":"231","volume-title":"Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells","author":"Kashiwagi","year":"2002","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-95","first-page":"114","volume-title":"Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells","author":"Nakazawa","year":"2002","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.73700-96","first-page":"1313","volume-title":"Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage","author":"Pang","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-97","first-page":"167","volume-title":"Antioxidant effects of alpha-, gamma- and succinate-tocopherols in guinea pig retina during ischemia-reperfusion injury","author":"Aydemir","year":"2004","journal-title":"Pathophysiology"},{"key":"key-10.4103\/0301-4738.73700-98","first-page":"627","volume-title":"Protective effects of various antioxidants during ischemia-reperfusion in the rat retina","author":"Dilsiz","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-99","first-page":"991","volume-title":"Protection of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract and bilobalide","author":"Janssens","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0301-4738.73700-100","first-page":"608","volume-title":"Calcium channel blockers in the management of low-tension and open-angle glaucoma","author":"Netland","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-101","first-page":"321","volume-title":"Expectations in the treatment of retinal diseases: Neuroprotection","author":"Osborne","year":"2001","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.73700-102","first-page":"5800","volume-title":"Neuroprotective Effects of Angiotensin II Type 1 Receptor Blocker in a Rat Model of Chronic Glaucoma","author":"Yang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-103","first-page":"253","volume-title":"The effect of aurintricarboxylic acid, an endonuclease inhibitor, on ischemia\/reperfusion damage in rat retina","author":"Lam","year":"1995","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.73700-104","first-page":"11784","volume-title":"Glatiramer acetate fights against Alzheimer\u2032s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1","author":"Butovsky","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.73700-105","first-page":"2284","volume-title":"Macrophage-derived factors stimulate optic nerve regeneration","author":"Yin","year":"2003","journal-title":"J Neurosci"},{"key":"key-10.4103\/0301-4738.73700-106","first-page":"489","volume-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2032s disease","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"key-10.4103\/0301-4738.73700-107","first-page":"1065","volume-title":"Morphological aspects of spinal cord autoimmune neuroprotection: Colocalization of T cells with B7--2 (CD86) and prevention of cyst formation","author":"Butovsky","year":"2001","journal-title":"FASEB J"},{"key":"key-10.4103\/0301-4738.73700-108","first-page":"381","volume-title":"Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective","author":"Butovsky","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"key-10.4103\/0301-4738.73700-109","first-page":"1304","volume-title":"Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: Implications for protective autoimmunity","author":"Barouch","year":"2002","journal-title":"FASEB J"},{"key":"key-10.4103\/0301-4738.73700-110","first-page":"997","volume-title":"Protective autoimmunity: Interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators","author":"Shaked","year":"2005","journal-title":"J Neurochem"},{"key":"key-10.4103\/0301-4738.73700-111","first-page":"6133","volume-title":"Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: Implications for neurodegeneration","author":"Kipnis","year":"2004","journal-title":"J Neurosci"},{"key":"key-10.4103\/0301-4738.73700-112","first-page":"15620","volume-title":"Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system","author":"Kipnis","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.73700-113","first-page":"1982","volume-title":"Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model","author":"Ishii","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-114","first-page":"511","volume-title":"Stem cells for neuroprotection in glaucoma","author":"Bull","year":"2008","journal-title":"Prog Brain Res"},{"key":"key-10.4103\/0301-4738.73700-115","first-page":"49","volume-title":"Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy","author":"Frank","year":"2009","journal-title":"BMC Neurosci"},{"key":"key-10.4103\/0301-4738.73700-116","first-page":"4244","volume-title":"Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma","author":"Bull","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-117","first-page":"93","volume-title":"Mitochondrial dysfunction and glaucoma","author":"Kong","year":"2009","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-118","first-page":"377","volume-title":"Bioenergetic-based neuroprotection and glaucoma","author":"Schober","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-119","first-page":"381","volume-title":"A randomized, blinded comparison of chloral hydrate and midazolam sedation in children undergoing echocardiography","author":"Wheeler","year":"2001","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.4103\/0301-4738.73700-120","first-page":"758","volume-title":"Human ganglion cells express the alpha-2 adrenergic receptor: Relevance to neuroprotection","author":"Kalapesi","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-121","first-page":"797","volume-title":"Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells","author":"Gao","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-122","first-page":"216","volume-title":"Alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia","author":"Donello","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0301-4738.73700-123","first-page":"S411","volume-title":"Alpha-2 adrenergic receptor activation by brimonidine reduces neuronal apoptosis through Akt (Protein Kinase B) dependent new synthesis of BCL-2","author":"Wheeler","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-124","first-page":"397","volume-title":"Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals","author":"Ballif","year":"2001","journal-title":"Cell Growth Differ"},{"key":"key-10.4103\/0301-4738.73700-125","first-page":"1326","volume-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis","author":"Xia","year":"1995","journal-title":"Science"},{"key":"key-10.4103\/0301-4738.73700-126","first-page":"4515","volume-title":"Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity","author":"Dong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-127","first-page":"376","volume-title":"The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients","author":"Krupin","year":"2005","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.73700-128","first-page":"175","volume-title":"Invited review: Neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma","author":"Osborne","year":"2005","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.73700-129","first-page":"2666","volume-title":"Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina","author":"Baptiste","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-130","first-page":"S162","volume-title":"Retinal ganglion cell dysfunction induced by hypoxia and glutamate: Potential neuroprotective effects of beta-blockers","author":"Gross","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-131","first-page":"611","volume-title":"Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects","author":"Hirooka","year":"2000","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0301-4738.73700-132","first-page":"522","volume-title":"Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels","author":"Melena","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-133","first-page":"111","volume-title":"Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells","author":"Zhang","year":"2003","journal-title":"Brain Res"},{"key":"key-10.4103\/0301-4738.73700-134","first-page":"759","volume-title":"Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: Comparison with other beta-adrenoceptor antagonists","author":"Chidlow","year":"2000","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0301-4738.73700-135","first-page":"317","volume-title":"Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels","author":"Melena","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0301-4738.73700-136","first-page":"134","volume-title":"Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing","author":"Tan","year":"2002","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-137","first-page":"331","volume-title":"Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina","author":"Osborne","year":"1999","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0301-4738.73700-138","unstructured":"DeSantis L, Dahlin D, Barnes G. A role for the calcium channel blocking-like action of betaxolol for providing therapeutic benefit to glaucoma patients. In: Drance S, editor. Update to glaucoma, ocular blood flow, and drug treatment. Amsterdam;New York: Kugler Publications; 1995. p. 137-43."},{"key":"key-10.4103\/0301-4738.73700-139","first-page":"10","volume-title":"Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina","author":"Goto","year":"2002","journal-title":"Brain Res"},{"key":"key-10.4103\/0301-4738.73700-140","first-page":"678","volume-title":"Influence of betaxolol and timolol on the visual fields of patients with glaucoma","author":"Messmer","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-141","first-page":"1","volume-title":"Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma","author":"Collignon-Brach","year":"1992","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.73700-142","first-page":"S149","volume-title":"Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma","author":"Collignon-Brach","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-143","first-page":"S156","volume-title":"Longterm visual field follow-up of glaucoma patients treated with beta-blockers","author":"Kaiser","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-144","first-page":"247","volume-title":"A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma","author":"Drance","year":"1998","journal-title":"J Glaucoma"},{"key":"key-10.4103\/0301-4738.73700-145","first-page":"100","volume-title":"The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: A 2-year follow-up study","author":"Vainio-Jylha","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-146","first-page":"199","volume-title":"Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients","author":"Araie","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-147","first-page":"288","volume-title":"Changing antiglaucoma therapy from timolol to betaxolol: Effect on ocular blood flow","author":"Rainer","year":"2003","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.73700-148","first-page":"509","volume-title":"The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol","author":"Miki","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.73700-149","first-page":"1003","volume-title":"Neuroprotective effect of latanoprost on rat retinal ganglion cells","author":"Kudo","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-150","first-page":"479","volume-title":"Latanoprost exerts neuroprotective activity in vitro and in vivo","author":"Drago","year":"2001","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0301-4738.73700-151","first-page":"63","volume-title":"Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: Clinical benefits in the treatment of glaucoma","author":"Melamed","year":"2002","journal-title":"Drugs Exp Clin Res"},{"key":"key-10.4103\/0301-4738.73700-152","first-page":"2640","volume-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures","author":"Hare","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-153","first-page":"1293","volume-title":"Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension","author":"Fuchsj\u03b4ger-Mayrl","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-154","first-page":"504","volume-title":"Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model","author":"Seki","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-155","first-page":"454","volume-title":"Dorzolamide and timolol saves retinal ganglion cells in glaucomatous adult rats","author":"Sarup","year":"2005","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.73700-156","doi-asserted-by":"crossref","unstructured":"Tsai JC, Song BJ, Wu L, Forbes M. Erythropoietin: A candidate neuroprotective agent in the treatment of glaucoma. J Glaucoma 2007;16:567-71.","DOI":"10.1097\/IJG.0b013e318156a556"},{"key":"key-10.4103\/0301-4738.73700-157","first-page":"425","volume-title":"Natural compounds: Evidence for a protective role in eye disease","author":"Ritch","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.73700-158","unstructured":"Castro-Sanchez AM, Moreno-Lorenzo C, Mataran-Penarrocha GA, Feriche-Fernandez-Castanys B, Granados-Gamez G, Quesada-Rubio JM. Connective Tissue Reflex Massage for Type 2 Diabetic Patients with Peripheral Arterial Disease: Randomized Controlled Trial. Evid Based Complement Alternat Med 2009.[In Press]."},{"key":"key-10.4103\/0301-4738.73700-159","first-page":"5152","volume-title":"Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats","author":"Kusari","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.73700-160","first-page":"551","volume-title":"Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): A 3-month, double-masked, randomised, placebo-controlled trial","author":"Wilhelm","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:54:43Z","timestamp":1786632883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.73700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":160,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"alternative-id":["73700"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.73700","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}